MRUS vs. NVO
Compare and contrast key facts about Merus N.V. (MRUS) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRUS or NVO.
Key characteristics
| MRUS | NVO | |
|---|---|---|
| YTD Return | 92.58% | 6.61% |
| 1Y Return | 131.27% | 8.99% |
| 3Y Return (Ann) | 22.08% | 26.24% |
| 5Y Return (Ann) | 27.34% | 32.72% |
| Sharpe Ratio | 2.29 | 0.34 |
| Sortino Ratio | 3.75 | 0.71 |
| Omega Ratio | 1.44 | 1.09 |
| Calmar Ratio | 4.37 | 0.37 |
| Martin Ratio | 11.73 | 1.07 |
| Ulcer Index | 11.32% | 9.61% |
| Daily Std Dev | 58.16% | 30.26% |
| Max Drawdown | -67.42% | -71.30% |
| Current Drawdown | -12.03% | -25.46% |
Fundamentals
| MRUS | NVO | |
|---|---|---|
| Market Cap | $3.63B | $479.61B |
| EPS | -$4.03 | $3.04 |
| PEG Ratio | 0.00 | 1.62 |
| Total Revenue (TTM) | $35.93M | $199.27B |
| Gross Profit (TTM) | -$1.53M | $169.07B |
| EBITDA (TTM) | -$253.79M | $98.21B |
Correlation
The correlation between MRUS and NVO is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRUS vs. NVO - Performance Comparison
In the year-to-date period, MRUS achieves a 92.58% return, which is significantly higher than NVO's 6.61% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRUS vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merus N.V. (MRUS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRUS vs. NVO - Dividend Comparison
MRUS has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.32%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRUS Merus N.V. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 1.32% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% | 1.72% |
Drawdowns
MRUS vs. NVO - Drawdown Comparison
The maximum MRUS drawdown since its inception was -67.42%, smaller than the maximum NVO drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for MRUS and NVO. For additional features, visit the drawdowns tool.
Volatility
MRUS vs. NVO - Volatility Comparison
Merus N.V. (MRUS) has a higher volatility of 8.73% compared to Novo Nordisk A/S (NVO) at 6.28%. This indicates that MRUS's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRUS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Merus N.V. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities